The oral hypoglycemic controversy. Stay as sweet as you are.
D002318:Cardiovascular Diseases / Q000139:chemically induced*; D003920:Diabetes Mellitus / Q000188:drug therapy*; D016883:Diabetic Ketoacidosis / Q000139:chemically induced; D004341:Drug Evaluation; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D007328:Insulin / Q000627:therapeutic use; D007603:Jurisprudence; D007773:Lactates; D010629:Phenformin / Q000009:adverse effects*; D010919:Placebos; D012107:Research Design; D014044:Tolbutamide / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
D007004:Hypoglycemic Agents; D007328:Insulin; D007773:Lactates; D010919:Placebos; D014044:Tolbutamide; D010629:Phenformin